"Bone Resorption" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bone loss due to osteoclastic activity.
| Descriptor ID |
D001862
|
| MeSH Number(s) |
C05.116.264 G11.427.213.150
|
| Concept/Terms |
Bone Resorption- Bone Resorption
- Bone Resorptions
- Resorption, Bone
- Resorptions, Bone
- Osteoclastic Bone Loss
- Bone Loss, Osteoclastic
- Bone Losses, Osteoclastic
- Loss, Osteoclastic Bone
- Losses, Osteoclastic Bone
- Osteoclastic Bone Losses
|
Below are MeSH descriptors whose meaning is more general than "Bone Resorption".
Below are MeSH descriptors whose meaning is more specific than "Bone Resorption".
This graph shows the total number of publications written about "Bone Resorption" by people in this website by year, and whether "Bone Resorption" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 2 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 2 | 2 | 4 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Resorption" by people in Profiles.
-
Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1. Elife. 2020 05 13; 9.
-
Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes. Bone. 2020 05; 134:115269.
-
Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions. Front Immunol. 2019; 10:1408.
-
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Sci Transl Med. 2019 05 29; 11(494).
-
Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia. Bone. 2019 07; 124:83-88.
-
Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults. BMJ Open. 2019 02 22; 9(2):e022471.
-
Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption. J Bone Miner Res. 2019 04; 34(4):681-698.
-
Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo. Sci Signal. 2019 01 08; 12(563).
-
A Novel Reliable and Efficient Procedure for Purification of Mature Osteoclasts Allowing Functional Assays in Mouse Cells. Front Immunol. 2018; 9:2567.
-
Bone protection by inhibition of microRNA-182. Nat Commun. 2018 10 05; 9(1):4108.